Sun Pharmaceutical Industries Ltd

Sun Pharma.Inds. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sun Pharmaceutical Industries Ltd

₹ 1,682 -0.40%
11 Jun 9:51 a.m.
sunpharma.com BSE: 524715 NSE: SUNPHARMA
About

Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to global market.[1] It is the largest pharmaceutical company in India.[2]

Key Points

Product Offerings
The company produces a range of generic and specialty medications for chronic and acute conditions. Its product portfolio includes generics, branded generics, specialty pharmaceuticals, advanced technology-based products, antiretrovirals, active pharmaceutical ingredients (APIs), and intermediates. It offers medications in multiple dosage forms, such as injectables, sprays, ointments, creams, liquids, tablets, and capsules. [1] [2]The company offers 26+ products in the global specialty market, with a strategic focus on dermatology, ophthalmology, and onco-dermatology segments. [3]

Website BSE NSE
  • Market Cap ₹ 4,03,448 Cr.
  • Current Price ₹ 1,682
  • High / Low ₹ 1,960 / 1,461
  • Stock P/E 94.2
  • Book Value ₹ 101
  • Dividend Yield 0.95 %
  • ROCE 16.8 %
  • ROE 17.8 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has been maintaining a healthy dividend payout of 122%

Cons

  • Stock is trading at 16.6 times its book value
  • Tax rate seems low
  • Company has high debtors of 186 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE Sensex Nifty 50 BSE 500 BSE Healthcare BSE 100

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
4,007 4,933 5,285 4,646 5,948 4,466 5,096 5,074 5,639 4,498 5,128 6,192 7,186
3,007 3,483 3,622 3,646 3,588 3,517 3,710 3,715 3,746 3,737 3,789 4,488 4,196
Operating Profit 1,000 1,450 1,663 999 2,361 949 1,386 1,359 1,894 761 1,339 1,703 2,989
OPM % 25% 29% 31% 22% 40% 21% 27% 27% 34% 17% 26% 28% 42%
-1,355 49 42 68 -2,817 14 107 7 119 83 86 68 132
Interest 91 87 93 131 161 158 194 215 218 216 244 216 217
Depreciation 354 374 384 430 412 415 393 400 393 370 286 291 292
Profit before tax -800 1,037 1,228 506 -1,030 390 907 751 1,402 258 896 1,265 2,612
Tax % 61% 2% 1% 4% -1% 2% 2% 4% 38% 8% 4% 7% 23%
-1,286 1,012 1,213 487 -1,021 381 889 721 868 238 863 1,181 2,000
EPS in Rs -5.36 4.22 5.06 2.03 -4.25 1.59 3.70 3.01 3.62 0.99 3.60 4.92 8.34
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
2,829 8,028 7,719 7,684 8,982 10,303 12,532 14,116 15,586 20,812 20,275 23,003
2,810 8,581 8,130 7,559 7,998 8,513 9,815 11,849 12,917 14,389 14,761 16,211
Operating Profit 19 -552 -410 125 985 1,790 2,717 2,267 2,669 6,423 5,514 6,793
OPM % 1% -7% -5% 2% 11% 17% 22% 16% 17% 31% 27% 30%
-2,700 205 367 504 171 23 1,506 93 -624 -2,609 320 369
Interest 18 551 574 224 388 541 408 268 388 472 784 893
Depreciation 102 661 464 422 487 553 562 1,236 1,350 1,601 1,601 1,238
Profit before tax -2,801 -1,559 -1,082 -17 280 719 3,253 856 307 1,741 3,450 5,031
Tax % 1% -5% 0% 36% -9% -14% 1% 2% 133% 3% 17% 15%
-2,829 -1,474 -1,088 -23 306 817 3,211 842 -100 1,691 2,858 4,283
EPS in Rs -13.66 -7.12 -4.52 -0.10 1.27 3.40 13.38 3.51 -0.42 7.05 11.91 17.85
Dividend Payout % -11% -42% -22% -3,677% 157% 81% 30% 214% -2,400% 163% 113% 90%
Compounded Sales Growth
10 Years: 11%
5 Years: 13%
3 Years: 14%
TTM: 13%
Compounded Profit Growth
10 Years: 17%
5 Years: 7%
3 Years: 73%
TTM: 40%
Stock Price CAGR
10 Years: 8%
5 Years: 29%
3 Years: 26%
1 Year: 13%
Return on Equity
10 Years: 6%
5 Years: 8%
3 Years: 15%
Last Year: 18%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 207 207 241 240 240 240 240 240 240 240 240 240
Reserves 7,201 22,579 21,650 20,773 22,083 22,604 24,156 26,699 24,348 23,508 23,454 24,100
2,409 6,811 5,829 6,047 6,884 6,437 6,406 7,358 5,074 7,791 11,227 11,138
4,548 7,849 6,547 6,810 7,585 8,434 7,608 9,438 11,103 9,448 6,143 7,796
Total Liabilities 14,364 37,446 34,266 33,869 36,792 37,714 38,410 43,735 40,765 40,987 41,065 43,273
1,267 3,185 3,575 4,039 4,645 4,978 5,229 9,669 9,713 8,712 7,737 7,364
CWIP 480 1,091 768 1,100 988 643 597 1,090 829 853 766 563
Investments 7,016 25,876 22,372 19,333 18,355 17,904 17,362 15,537 15,549 12,613 12,430 12,410
5,601 7,294 7,552 9,397 12,804 14,189 15,223 17,438 14,675 18,810 20,132 22,936
Total Assets 14,364 37,446 34,266 33,869 36,792 37,714 38,410 43,735 40,765 40,987 41,065 43,273

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-2,405 149 -1,254 -1,621 -1,171 1,242 1,306 -417 7,636 507 -292 4,199
517 2,642 3,640 2,381 1,394 431 1,483 1,452 -2,697 -686 -265 -210
1,742 -2,674 -2,368 -753 -272 -1,469 -2,871 -1,000 -4,871 169 474 -3,831
Net Cash Flow -145 117 17 7 -50 205 -82 36 68 -9 -84 158

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 126 82 94 129 214 178 180 170 99 125 159 186
Inventory Days 315 227 260 256 218 277 210 245 220 240 223 231
Days Payable 130 164 216 229 262 214 170 288 175 188 171 210
Cash Conversion Cycle 311 146 138 155 170 242 220 127 144 177 211 207
Working Capital Days 370 -85 9 -35 83 62 122 110 -26 131 183 169
ROCE % 0% -6% -3% -0% 5% 8% 11% 4% 8% 17% 13% 17%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
54.48% 54.48% 54.48% 54.48% 54.48% 54.48% 54.48% 54.48% 54.48% 54.48% 54.48% 54.48%
14.95% 16.00% 16.87% 16.88% 16.48% 16.78% 17.08% 17.72% 17.23% 18.01% 18.04% 17.96%
19.66% 19.64% 19.08% 19.18% 19.65% 19.56% 19.42% 18.71% 19.17% 18.48% 18.43% 18.58%
0.00% 0.06% 0.06% 0.06% 0.09% 0.10% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11%
10.91% 9.80% 9.52% 9.38% 9.28% 9.05% 8.92% 8.97% 9.00% 8.89% 8.92% 8.86%
No. of Shareholders 6,47,1676,43,5126,32,3376,25,2526,24,5616,16,5886,12,6266,31,3926,73,2176,57,3176,89,6237,04,983

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls